IDARUBICIN vs IFOSFAMIDE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
IDARUBICIN vs IFOSFAMIDE: Safety Overview
| Metric | IDARUBICIN | IFOSFAMIDE |
|---|---|---|
| Total FAERS Reports | 5,038 | 17,004 |
| Deaths Reported | 1,260 | 3,365 |
| Death Rate | 25.0% | 19.8% |
| Hospitalizations | 1,856 | 5,230 |
| Average Patient Age | 44.8 yrs | 36.2 yrs |
| % Female Patients | 46.2% | 41.7% |
| FDA Approval Date | Apr 25, 1995 | Apr 4, 2007 |
| Manufacturer | Pfizer Laboratories Div Pfizer Inc | Baxter Healthcare Corporation |
| Route | INTRAVENOUS | INTRAVENOUS |
| Marketing Status | Discontinued | Prescription |